BIG PHARMA 200% TARIFFS

In a forceful move to prioritize American industry and secure our nation’s vital supply chains, President Trump announced plans to impose sweeping tariffs on imported pharmaceuticals and semiconductors—essential sectors long outsourced to foreign nations at America’s expense. Trump declared that pharmaceuticals could face tariffs as steep as 200%, effectively sending a clear message to global manufacturers: bring critical production back to U.S. soil, or pay the price. Speaking from the White House during a Cabinet meeting, the President gave companies about a year to realign before the penalties hit, offering a fair but firm timeline for reshoring. This bold action underscores a continued America First economic policy, aimed at ending dependency on foreign suppliers and restoring U.S. dominance in industries crucial to national security and public health.